Lamivudine

Back to search

Molecule Structure

Scientific Name

Lamivudine

Description of the Drug

Lamivudine is a reverse transcriptase inhibitor used to treat HIV and hepatitis B infections.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00709

Brand Name(s)

Epivir, Epivir-hbv, Lamivudine, Zeffix

Company Owner(s)

Cipla Ltd, Glaxosmithkline, Macleods Pharmaceuticals Ltd, Laurus Labs Ltd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Merck Sharp And Dohme Corp A Sub Of Merck And Co Inc, Micro Labs Ltd, Anda Repository Llc, Pharmacare Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA polymerase/reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL2362994
DNA NUCLEIC-ACID INHIBITOR CHEMBL2363048
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247
DNA NUCLEIC-ACID INHIBITOR CHEMBL2363046
DNA NUCLEIC-ACID INHIBITOR CHEMBL2363047

Unichem Links

SureChEMBL SCHEMBL109675
PharmGKB PA450163
Human Metabolome Database HMDB0014847
DrugBank DB00709
PubChem: Thomson Pharma 14798125 15121620
PubChem 60825
Mcule MCULE-8483986532 MCULE-2096184994
NMRShiftDB 70000621
LINCS LSM-5215
Nikkaji J457.051K
PDBe 3TC
BindingDB 50366817
DrugCentral 1539
Brenda 229605 229604 6246
ChemicalBook CB1290608
rxnorm LAMIVUDINE EPIVIR
PubChem: Drugs of the Future 12014700
KEGG Ligand C07065
ChEBI 63577
ZINC ZINC000000012346